Abstract
We report a case of acute hepatitis B after autologous stem cell transplantation (ASCT) in a patient with low-grade non-Hodgkin’s lymphoma. At diagnosis of the hematological disease, the patient had the characteristic serology of a previous hepatitis B infection, being Ag HBs negative, hepatitis B virus core antibody positive (anti-HBC) and hepatitis B virus surface antibody weakly positive. He developed fatal hepatitis B after autologous stem cell transplantation, suggesting reactivation consequent to immunosuppression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Senecal, D., Pichon, E., Dubois, F. et al. Acute hepatitis B after autologous stem cell transplantation in a man previously infected by hepatitis B virus. Bone Marrow Transplant 24, 1243–1244 (1999). https://doi.org/10.1038/sj.bmt.1702039
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702039
- Springer Nature Limited
Keywords
This article is cited by
-
Hepatitis B virus management to prevent reactivation after chemotherapy: a review
Supportive Care in Cancer (2012)
-
Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia
International Journal of Hematology (2001)
-
Hepatitis B viremia in a patient with documented previous HBV immunity after autologous transplantation of highly purified PBSC
Bone Marrow Transplantation (2000)
-
Response
Bone Marrow Transplantation (2000)